Home / Share Price Target / Eris
Eris Lifesciences Share Price Target 2024, 2025, 2026 to 2039 With Charts
Eris Lifesciences Limited | |||
 | Symbol: ERIS | ||
| Price: ₹1,366.9 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Eris Lifesciences Brief Company Overview
- 1.1: Company Overview: Eris Lifesciences Limited
- 1.1.1: Reputation and Commitment:
- 1.2: Eris Lifesciences Financial Performance
- 1.2.1: Is Eris Lifesciences A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Eris Lifesciences Share Price Target For 2024
- 2.1.1: Eris Lifesciences Share Price Target Table For 2024
- 2.1.2: Summary: Eris Lifesciences Share Price Prediction For 2024
- 2.2: Eris Lifesciences Share Price Target For 2025
- 2.2.1: Eris Lifesciences Share Price Target Table For 2025
- 2.2.2: Summary: Eris Lifesciences Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Eris Lifesciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Eris Lifesciences Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Eris Lifesciences Past Performance
Eris Lifesciences Brief Company Overview
Company Overview: Eris Lifesciences Limited
Eris Lifesciences Limited, established in 2007, is an Indian pharmaceutical company based in Ahmedabad. It specializes in the manufacturing, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies.
Eris Lifesciences offers a comprehensive range of branded formulations catering to various therapeutic areas, including anti-diabetes, anti-infective, cardiovascular, dermatology, gastroenterology, neuropsychiatry, pain management, respiratory, and vitamins/minerals/nutrients.
The company also provides patient care services such as blood pressure measurement, electrocardiogram measurement, glucose monitoring, sleep study, and ante-natal care solutions.
Eris Lifesciences has a strong market presence across India, distributing its products through wholesale drug distributors, stockiest, and retail pharmacies.
Reputation and Commitment:
Eris Lifesciences has earned a reputation for quality and innovation in the pharmaceutical industry. The company is committed to providing affordable and accessible healthcare solutions to its customers.
Eris Lifesciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 17,778.84 Crore | Market valuation of Eris Lifesciences's shares. |
| Revenue (TTM) | 2,485.28 Crore | Total revenue generated by Eris Lifesciences over the past twelve months. |
| Net Income (TTM) | +348.46 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 24.9% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 14.02% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +47.59% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -25.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 86.07 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2,734.82 Crore | Sum of Eris Lifesciences's current & long-term financial obligations. |
| Total Cash | 242.54 Crore | Total amount of liquid funds available to Eris Lifesciences. |
| Beta | 0.32 | Beta is less than 1 indicating that the Eris Lifesciences's price is less volatile than the market. |
Is Eris Lifesciences A Good Buy For Long Term?
Eris Lifesciences, a mid-cap stock with a market capitalization of ₹18,425.94 crore, shows strong recent performance: 57.38% return over the past 12 months and 133.25% over three years. However, Q2 2024-25 results reveal a concerning 25.8% drop in earnings year-on-year, despite a 47.59% revenue increase quarter-on-quarter. A significant debt of ₹2,734.82 crore against a cash balance of ₹242.54 crore raises concerns. While its 14.02% profit margin is moderate, the high debt level warrants caution. Considering these factors, it's an average buy for the long term; further investigation into the reasons for the earnings decline is crucial before a stronger recommendation can be made.
To predict the Eris Lifesciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Eris Lifesciences Share Price Target For 2024
The line chart displays the monthly closing prices of Eris Lifesciences with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Eris Lifesciences shares in 2024, see the table below.
Eris Lifesciences Share Price Target Table For 2024
| Eris Lifesciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1403.89 (+2.7%) | Fibonacci Extension Level 199% |
| 2024 Target 2 | 1389.38 (+1.64%) | Custom Fibonacci Extension Lvl 82% |
| 2024 Target 1 | 1373.37 (+0.47%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 1366.90 | Eris Lifesciences's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 1363.75 (-0.24%) | Price Action: 21 Oct 2024 High |
| Stop Loss 2 | 1350.00 (-1.24%) | Price Action: 29 Oct 2024 High |
| Stop Loss 3 | 1335.00 (-2.34%) | Price Action: 17 Oct 2024 Low |
Summary: Eris Lifesciences Share Price Prediction For 2024
In summary, Eris Lifesciences has surged by ₹456.90, achieving a notable +50.21% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Eris Lifesciences for 2024 predicts an additional rise of 0.47% to 2.7% by the end of 2024 with three potential targets T1: 1373.37, T2: 1389.38, T3: 1403.89. Stop Loss at SL1: 1363.75, SL2: 1350.00, SL3: 1335.00.
Eris Lifesciences has a 52-week high of ₹1522.05, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹809.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Eris Lifesciences.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Eris Lifesciences Share Price Target For 2025
The line chart displays the monthly closing prices of Eris Lifesciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Eris Lifesciences shares in 2025, see the table below.
Eris Lifesciences Share Price Target Table For 2025
| Eris Lifesciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1800.79 (+31.74%) | Price Action: Chart |
| 2025 Target 2 | 1767.21 (+29.28%) | Price Action: Chart |
| 2025 Target 1 | 1749.71 (+28%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1366.90 | Eris Lifesciences's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 1279.05 (-6.43%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 2 | 1261.90 (-7.69%) | Price Action: 28 Oct 2024 Low |
| Stop Loss 3 | 1218.09 (-10.89%) | Technical Indicator: MA100 |
Summary: Eris Lifesciences Share Price Prediction For 2025
In summary, Eris Lifesciences has surged by ₹456.90, achieving a notable +50.21% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Eris Lifesciences for 2025 predicts an additional rise of 28% to 31.74% by the end of 2025 with three potential targets T1: 1749.71, T2: 1767.21, T3: 1800.79. Stop Loss at SL1: 1279.05, SL2: 1261.90, SL3: 1218.09.
Eris Lifesciences has a All-Time high of ₹1522.05, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹809.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Eris Lifesciences, we have created a specific page for that check here: Eris Lifesciences Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Eris Lifesciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Eris Lifesciences share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 15.43% over the next 15 years.
For complete year by year Eris Lifesciences long term share price target from 2024, 2025 to 2039 check the below table.
Eris Lifesciences Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Eris Lifesciences Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,366.9 | [Current Price] |
| 2024 | ₹1,489.84 | 8.99% |
| 2025 | ₹2,133.25 | 43.18% |
| 2026 | ₹2,685.73 | 25.89% |
| 2027 | ₹3,373.18 | 25.59% |
| 2028 | ₹4,074.49 | 20.79% |
| 2029 | ₹4,681.03 | 14.88% |
| 2030 | ₹5,332.21 | 13.91% |
| 2031 | ₹5,783.95 | 8.47% |
| 2032 | ₹6,534.97 | 12.98% |
| 2033 | ₹7,290.7 | 11.56% |
| 2034 | ₹7,872.22 | 7.97% |
| 2035 | ₹8,531.16 | 8.37% |
| 2036 | ₹8,882.18 | 4.11% |
| 2037 | ₹9,696.76 | 9.17% |
| 2038 | ₹10,506.91 | 8.35% |
| 2039 | ₹11,106.5 | 5.7% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Eris Lifesciences Past Performance
- In 2017, Eris Lifesciences opening price was ₹599
- As of Thu 21 Nov 2024 the price stands at ₹1,366.9.
- This represents a Compound Annual Growth Rate (CAGR) of 10.86%.
- In 7 years, an investment of 10,000 would have become ₹22,819.69.
As we wrap up, we hope you like our study on Eris Lifesciences share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Eris Lifesciences Share Price History
- Eris Lifesciences Price Target Tomorrow
- Eris Lifesciences Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
